DrugPatentWatch Database Preview
Sanofi Synthelabo Company Profile
Summary for Sanofi Synthelabo
| Patents: | 63 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| BLAs: | 2 |
US Patents for Sanofi Synthelabo
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,016,412 | YALE UNIVERSITY (New Haven, CT) | 2021-05-01 | RX | search | |
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,111,968 | CureVac AG (Tubingen, DE) | 2032-02-15 | RX | search | |
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,117,943 | YALE UNIVERSITY (New Haven, CT) | 2039-02-26 | RX | search | |
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,182,561 | ALEXION PHARMACEUTICALS, INC. (New Haven, CT) | 2024-12-29 | RX | search | |
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,195,188 | ChemoCentryx, Inc. (Mountain View, CA) | 2036-06-13 | RX | search | |
| Sanofi Synthelabo | ELITEK | rasburicase | VIAL; INTRAVENOUS | 103946 | 001 | 2002-07-12 | 10,398,685 | ChemoCentryx, Inc. (Mountain View, CA) | 2036-06-13 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
Similar Applicant Names
Companies are sometimes listed under multiple names.
This search can help find similar names.
This search can help find similar names.
